Pharmacokinetic study of cisplatin and infusional etoposide phosphate in advanced breast cancer with correlation of response to topoisomerase IIalpha expression.
Jeremy Braybrooke(University Hospitals Bristol NHS Foundation Trust), Denis Talbot(Cancer Research UK), Srinivasan Madhusudan(Nottingham University Hospitals NHS Trust), Theresa Davis, Helen Turley(John Radcliffe Hospital), Adrian L. Harris(University of Oxford), Sue Wilner, N C Levitt, Simon Joel(Queen Mary University of London)
PubMed
October 15, 2003
Cited by 23
Related Papers
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
|New England Journal of Medicine|2010|4.5k
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
|Proceedings of the National Academy of Sciences|2003|2k